Home › NDC Lookup › Labelers › Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 17772 (Supernus Pharmaceuticals, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

48
Package NDCs
24
Products
24
Active listings
0
Discontinued
4
Ingredients
0
Therapeutic classes
3
Dosage forms
15
With NADAC pricing

Portfolio

Top ingredients
topiramate 8
OXCARBAZEPINE 6
viloxazine hydrochloride 6
AMANTADINE 4
By dosage form
CAPSULE, EXTENDED RELEASE 14
TABLET 6
CAPSULE, COATED PELLETS 4

Browse records — 24 products

Drug / product Billing NDC NADAC / unit Status
GOCOVRI AMANTADINE 137 mg/1 CAPSULE, COATED PELLETS Supernus · NDC 17772-0170-21 · 21 CAPSULE, COATED PELLETS in 1 BOTTLE (17772-170-21) 17772-0170-21 — On market View →
GOCOVRI AMANTADINE 68.5 mg/1 CAPSULE, COATED PELLETS Supernus · NDC 17772-0085-21 · 21 CAPSULE, COATED PELLETS in 1 BOTTLE (17772-085-21) 17772-0085-21 — On market View →
GOCOVRI AMANTADINE 68.5 mg/1 CAPSULE, COATED PELLETS Supernus · NDC 17772-0085-21 · 21 CAPSULE, COATED PELLETS in 1 BOTTLE (17772-085-21) 17772-0085-21 — On market View →
GOCOVRI AMANTADINE 137 mg/1 CAPSULE, COATED PELLETS Supernus · NDC 17772-0170-21 · 21 CAPSULE, COATED PELLETS in 1 BOTTLE (17772-170-21) 17772-0170-21 — On market View →
OXTELLAR XR OXCARBAZEPINE 300 mg/1 TABLET Supernus · NDC 17772-0122-01 · 100 TABLET in 1 BOTTLE (17772-122-01) 17772-0122-01 $12.752 /unit · NADAC On market View →
OXTELLAR XR OXCARBAZEPINE 600 mg/1 TABLET Supernus · NDC 17772-0123-01 · 100 TABLET in 1 BOTTLE (17772-123-01) 17772-0123-01 $23.299 /unit · NADAC On market View →
OXTELLAR XR OXCARBAZEPINE 150 mg/1 TABLET Supernus · NDC 17772-0121-01 · 100 TABLET in 1 BOTTLE (17772-121-01) 17772-0121-01 $9.025 /unit · NADAC On market View →
OXTELLAR XR OXCARBAZEPINE 600 mg/1 TABLET Supernus · NDC 17772-0123-01 · 100 TABLET in 1 BOTTLE (17772-123-01) 17772-0123-01 $23.299 /unit · NADAC On market View →
OXTELLAR XR OXCARBAZEPINE 150 mg/1 TABLET Supernus · NDC 17772-0121-01 · 100 TABLET in 1 BOTTLE (17772-121-01) 17772-0121-01 $9.025 /unit · NADAC On market View →
OXTELLAR XR OXCARBAZEPINE 300 mg/1 TABLET Supernus · NDC 17772-0122-01 · 100 TABLET in 1 BOTTLE (17772-122-01) 17772-0122-01 $12.752 /unit · NADAC On market View →
QELBREE viloxazine hydrochloride 100 mg/1 CAPSULE, EXTENDED RELEASE Supernus · NDC 17772-0131-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-01) 17772-0131-01 — On market View →
QELBREE viloxazine hydrochloride 150 mg/1 CAPSULE, EXTENDED RELEASE Supernus · NDC 17772-0132-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-132-01) 17772-0132-01 — On market View →
QELBREE viloxazine hydrochloride 200 mg/1 CAPSULE, EXTENDED RELEASE Supernus · NDC 17772-0133-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-133-01) 17772-0133-01 — On market View →
QELBREE viloxazine hydrochloride 100 mg/1 CAPSULE, EXTENDED RELEASE Supernus · NDC 17772-0131-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-01) 17772-0131-01 — On market View →
QELBREE viloxazine hydrochloride 200 mg/1 CAPSULE, EXTENDED RELEASE Supernus · NDC 17772-0133-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-133-01) 17772-0133-01 — On market View →
QELBREE viloxazine hydrochloride 150 mg/1 CAPSULE, EXTENDED RELEASE Supernus · NDC 17772-0132-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-132-01) 17772-0132-01 — On market View →
Trokendi XR topiramate 25 mg/1 CAPSULE, EXTENDED RELEASE Supernus · NDC 17772-0101-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-101-01) 17772-0101-01 $11.794 /unit · NADAC On market View →
Trokendi XR topiramate 100 mg/1 CAPSULE, EXTENDED RELEASE Supernus · NDC 17772-0103-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-103-01) 17772-0103-01 $30.287 /unit · NADAC On market View →
Trokendi XR topiramate 200 mg/1 CAPSULE, EXTENDED RELEASE Supernus · NDC 17772-0104-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-104-01) 17772-0104-01 $41.565 /unit · NADAC On market View →
Trokendi XR topiramate 50 mg/1 CAPSULE, EXTENDED RELEASE Supernus · NDC 17772-0102-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-102-01) 17772-0102-01 $15.364 /unit · NADAC On market View →
Trokendi XR topiramate 50 mg/1 CAPSULE, EXTENDED RELEASE Supernus · NDC 17772-0102-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-102-01) 17772-0102-01 $15.364 /unit · NADAC On market View →
Trokendi XR topiramate 200 mg/1 CAPSULE, EXTENDED RELEASE Supernus · NDC 17772-0104-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-104-01) 17772-0104-01 $41.565 /unit · NADAC On market View →
Trokendi XR topiramate 100 mg/1 CAPSULE, EXTENDED RELEASE Supernus · NDC 17772-0103-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-103-01) 17772-0103-01 $30.287 /unit · NADAC On market View →
Trokendi XR topiramate 25 mg/1 CAPSULE, EXTENDED RELEASE Supernus · NDC 17772-0101-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-101-01) 17772-0101-01 $11.794 /unit · NADAC On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.